跳至主要内容
临床试验/NCT00256490
NCT00256490已完成不适用

Early Evaluation of the Response of Large B Cell Non Hodgkin's Lymphoma to Chemotherapy by Positron Emission Tomography Coupled With Computed Tomography (PET/CT)

Eric Turcotte2 个研究点 分布在 1 个国家目标入组 82 人开始时间: 2005年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Eric Turcotte
入组人数
82
试验地点
2
主要终点
Disease free survival at 2 years

研究概览

简要总结

Patients affected with non-Hodgkin's large B-cell lymphoma are treated by chemotherapy. The evaluation of the response to this treatment is made by Positron Emission Tomography (PET/CT) in many centres where this technology is available. Presently PET scans and CT scans are being performed before treatment, after 4 cycles of chemotherapy and a few months after the end of treatment.

The goal of this study is to determine if it is possible to evaluate the efficiency of chemotherapy treatments after one cycle of treatment instead of waiting after 4 cycles, using a new scanner that combines PET and CT modalities. Data available from studies on these combined exams suggest that PET/CT helps to rapidly evaluate the response of the chemotherapy treatment. We also want to verify if some pathological characteristics measured from tumor cells will enable doctors to predict in advance the response to treatment.

详细描述

Participation in this study involves 4 PET/CT exams, which occur before the treatments start, after the first cycle of chemotherapy, after 4 cycles of chemotherapy and then 12 weeks after the end of the treatments. The only additional test performed in this study compared to the regular follow-up of patients that are not in this study is the PET/CT exam after the first cycle. Your participation in this study will not affect treatment since the results of the first PET/CT test will not be communicated. All other tests results will be available in the medical record.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Newly diagnosed large B cells non Hodgkin's lymphoma, CD20 positive
  • Chemotherapy treatments planned (R-CHOP) but not started

排除标准

  • Pregnancy (determined by urinary β-HCG and blood test)
  • Patients younger than 18 years
  • Unable to tolerate the procedure (30 minutes laying down on the back)
  • No chemotherapy treatment planned secondary to the patient's health performance
  • Previous lymphoma that has been treated with chemotherapy with the exception of stade I lymphoma treated only with radiotherapy.
  • All lymphoma other than large cell Non Hodgkin's lymphoma

结局指标

主要结局

Disease free survival at 2 years

次要结局

未报告次要终点

研究者

发起方
Eric Turcotte
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Eric Turcotte

MD

Université de Sherbrooke

研究点 (2)

Loading locations...

相似试验